The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 21 results:
Author Title Type [ Year(Asc)]
Filters: Author is Zegkos, Thomas  [Clear All Filters]
2023
Papanastasiou, C. A., Kampaktsis P. N., Bazmpani M-A., Zegkos T., Efthimiadis G., Tsapas A., et al. (2023).  Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.. JACC Cardiovasc Imaging. 16(3), 399-401.
2022
Doumas, A., Zegkos T., Parcharidou D., Gossios T., Ntelios D., Chatzileontiadou S., et al. (2022).  A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report.. Hell J Nucl Med. 25(2), 216-219.
Papanastasiou, C. A., Bazmpani M-A., Kokkinidis D. G., Zegkos T., Efthimiadis G., Tsapas A., et al. (2022).  The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.. Int J Cardiol. 368, 94-103.
2020
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy. Hellenic Journal of Cardiology.
Ntelios, D., Efthimiadis G., Zegkos T., Didagelos M., Katopodi T., Meditskou S., et al. (2020).  Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy.. Hellenic J Cardiol.
Zegkos, T., Panagiotidis T., Parcharidou D., & Efthimiadis G. (2020).  Emerging concepts in arrhythmogenic dilated cardiomyopathy.. Heart Fail Rev.
Ntelios, D., Parcharidou D., Zegkos T., Paraskevaidis S., Manolakos E., Papoulidis I., et al. (2020).  The multiple faces of Danon disease.. Hellenic J Cardiol.
Parcharidou, D., Zegkos T., Ntelios D., Panagiotidis T., Katranas S., Siskos A., et al. (2020).  The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort.. J Cardiovasc Med (Hagerstown). 21(6), 428-434.
Efthimiadis, G., Zegkos T., Meditskou S., Karamitsos T., Manolakos E., Papoulidis I., et al. (2020).  A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype.. Hellenic J Cardiol.
Zegkos, T., Ntelios D., Parcharidou D., Katranas S., Panagiotidis T., Rouskas P., et al. (2020).  The Prognostic Value of Left Atrial Deformation Parameters for Sudden Arrhythmic Events in Hypertrophic Cardiomyopathy.. J Am Soc Echocardiogr. 33(10), 1276-1277.e1.
2018
Zegkos, T., Parcharidou D., Ntelios D., Efthimiadis G., & Karvounis H. (2018).  The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy: Current and Future Perspectives.. Cardiol Rev. 26(3), 130-136.
2017
Meditskou, S., Mylonakis P., Giannoglou D., Zegkos T., Pagourelias E., Protonotarios N., et al. (2017).  Adipositas cordis: A case report study and a brief review of the literature.. Hellenic J Cardiol. 58(3), 239-242.
Zegkos, T., Efthimiadis G. K., Parcharidou D. G., Gossios T. D., Giannakoulas G., Ntelios D., et al. (2017).  Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.. Hellenic J Cardiol. 58(5), 331-339.
Ntelios, D., Meditskou S., Efthimiadis G., Pitsis A., Nikolakaki E., Girtovitis F., et al. (2017).  Elevated plasma levels of miR-29a are associated with hemolysis in patients with hypertrophic cardiomyopathy. Clinica Chimica Acta. 471, 321 - 326.
Ntiloudi, D., Zegkos T., Koutsakis A., Giannakoulas G., & Karvounis H. (2017).  Pregnancy in Patients With Congenital Heart Disease. Cardiology in Review. 25(6), 326 - 330.
Ntiloudi, D., Zegkos T., Koutsakis A., Giannakoulas G., & Karvounis H. (2017).  Pregnancy in Patients With Congenital Heart Disease: A Contemporary Challenge.. Cardiol Rev. 25(6), 326-330.
Ntiloudi, D., Zegkos T., Bazmpani M. Anna, Parcharidou D., Panagiotidis T., Hadjimiltiades S., et al. (2017).  Pregnancy outcome in women with congenital heart disease: A single-center experience.. Hellenic J Cardiol.
Ntiloudi, D., Zegkos T., Bazmpani M. Anna, Parcharidou D., Panagiotidis T., Hadjimiltiades S., et al. (2017).  Pregnancy outcome in women with congenital heart disease: A single-center experience. Hellenic Journal of Cardiology.
2016
Zegkos, T., Kitas G., & Dimitroulas T. (2016).  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.. Ther Adv Musculoskelet Dis. 8(3), 86-101.
Efthimiadis, G. K., Pagourelias E., Zegkos T., Parcharidou D., Panagiotidis T., Arvanitaki A., et al. (2016).  An Overview of Pharmacotherapy in Hypertrophic Cardiomyopathy: Current Speculations and Clinical Perspectives.. Rev Cardiovasc Med. 17(3-4), 115-123.
2014
Efthimiadis, G. K., Zegkos T., Meditskou S., & Hadjimiltiades S. (2014).  Perspectives on sudden death prevention in hypertrophic cardiomyopathy.. Cardiol Rev. 22(5), 210-6.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.